Phospholipase A(2) subclasses in acute respiratory distress syndrome

dc.contributor.authorKitsiouli, E.en
dc.contributor.authorNakos, G.en
dc.contributor.authorLekka, M. E.en
dc.date.accessioned2015-11-24T16:44:29Z
dc.date.available2015-11-24T16:44:29Z
dc.identifier.issn0925-4439-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8807
dc.rightsDefault Licence-
dc.subjectalien
dc.subjectardsen
dc.subjectphospholipase a(2)en
dc.subjectpla(2)en
dc.subjectpaf-ahen
dc.subjectlung surfactanten
dc.subjectinhibitors of pla(2)en
dc.subjectacute lung injuryen
dc.subjectplatelet-activating-factoren
dc.subjectarachidonic-acid releaseen
dc.subjectsurfactant protein-aen
dc.subjectbronchoalveolar lavage fluiden
dc.subjectairway epithelial-cellsen
dc.subjectintestinal ischemia-reperfusionen
dc.subjectx secreted phospholipase-a(2)en
dc.subjectsmooth-muscle-cellsen
dc.subjectm-type receptoren
dc.titlePhospholipase A(2) subclasses in acute respiratory distress syndromeen
heal.abstractphospholipases A(2), (PLA(2)) catalyse the cleavage of fatty acids esterified at the sn-2 position of glycerophospholipids. In acute lung injury-acute respiratory distress syndrome (ALI-ARDS) several distinct isoenzymes appear in lung cells and fluid Some are capable to trigger molecular events leading to enhanced inflammation and lung damage and others have a role in lung surfactant recycling preserving lung function Secreted forms (groups sPLA(2)-IIA, -V, -X) can directly hydrolyze surfactant phospholipids Cytosolic PLA(2) (cPLA(2)-IVA) requiring Ca(2+) has a preference for arachidonate, the precursor of etcosanoids which participate in the inflammatory response in the lung. Ca(2+) independent intracellular PLA(2)s (iPLA(2)) take part in surfactant phospholipids turnover within alveolar cells Acidic Ca(2+) -independent PLA(2) (aiPLA(2)). of lysosomal origin. has additionally antioxidant properties, (peroxiredoxin VI activity). and participates in the formation of dipalmitoyl-phosphatidylcholine in lung surfactant. PAF-AH degrades PAF. a potent mediator of inflammation, and oxidatively fragmented phospholipids but also leads to toxic metabolites. Therefore, the regulation of PLA(2) isoforms could be a valuable approach for ARDS treatment. (C) 2009 Elsevier B.V All rights reserved.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primaryDOI 10.1016/j.bbadis.2009.06.007-
heal.identifier.secondary<Go to ISI>://000271071600002-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0925443909001380/1-s2.0-S0925443909001380-main.pdf?_tid=25588c005c8a30f4395b2acd39f5691a&acdnat=1333033686_41946e413ba999479a179718bb8def8c-
heal.journalNameBiochimica Et Biophysica Acta-Molecular Basis of Diseaseen
heal.journalTypepeer reviewed-
heal.languageen-
heal.publicationDate2009-
heal.publisherElsevieren
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: